California State Teachers Retirement System (CalSTRS)’s MiNK Therapeutics INKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-155
Closed -$1.47K 3077
2024
Q2
$1.47K Hold
155
﹤0.01% 3073
2024
Q1
$1.41K Hold
155
﹤0.01% 3037
2023
Q4
$1.66K Sell
155
-352
-69% -$3.67K ﹤0.01% 3062
2023
Q3
$5.93K Hold
507
﹤0.01% 3079
2023
Q2
$10.6K Buy
+507
New +$10.2K ﹤0.01% 3087
2022
Q2
Sell
-71
Closed -$2K 3225
2022
Q1
$2K Buy
+71
New +$2.13K ﹤0.01% 3205

Other funds holding INKT

California State Teachers Retirement System (CalSTRS)'s INKT Position: Q3 2024 in Review

California State Teachers Retirement System (CalSTRS) sold out of MiNK Therapeutics (INKT) in Q3 2024, closing a stake of 155 shares — an estimated $1.47K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in INKT in Q1 2022 and held it in 6 quarters. The position peaked at $10.6K in Q2 2023. 24 funds tracked by Wall St. Rank hold INKT as of Q3 2024.

  • California State Teachers Retirement System (CalSTRS) reported no remaining MiNK Therapeutics position as of Q3 2024 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 155 MiNK Therapeutics shares in Q3 2024, an estimated $1.47K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in MiNK Therapeutics in Q1 2022 and held it in 6 quarters.
  • California State Teachers Retirement System (CalSTRS)'s MiNK Therapeutics position peaked at $10.6K in Q2 2023.
  • 24 funds tracked by Wall St. Rank held MiNK Therapeutics as of Q3 2024.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q3 2024, filed 14 Nov 2024.